Zejula and Bruxism - a phase IV clinical study of FDA data

Summary:

Bruxism is reported as a side effect among people who take Zejula (niraparib tosylate), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Zofran, and have Ovarian cancer.

The phase IV clinical study analyzes which people have Bruxism when taking Zejula. It is created by eHealthMe based on reports of 22,010 people who have side effects when taking Zejula from the FDA, and is updated regularly.

What is Zejula?

Zejula has active ingredients of niraparib tosylate. eHealthMe is studying from 22,014 Zejula users. Check the latest studies of Zejula.

What is Bruxism?

Bruxism (habitual grinding of the teeth, typically during sleep) is found to be associated with 590 drugs and 983 conditions by eHealthMe. Check the latest studies of Bruxism.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 05, 2026

22,010 people reported to have side effects when taking Zejula.
Among them, 24 people (0.11%) have Bruxism.

Among these 24 people:

How long have people been on Zejula when they have Bruxism? *

What is the gender of people who have Bruxism when taking Zejula? *

female: 100 %
male: 0.0 %

What is the age of people who have Bruxism when taking Zejula? *

What are other drugs people take besides Zejula? *

What are other side effects people have besides Bruxism? *

Fatigue (feeling of tiredness): 19 people, 79.17%
Nausea (feeling of having an urge to vomit): 14 people, 58.33%
Thrombocytopenia (decrease of platelets in blood): 14 people, 58.33%
Constipation: 10 people, 41.67%
Headache (pain in head): 9 people, 37.50%
Malaise (a feeling of general discomfort or uneasiness): 9 people, 37.50%
Carbohydrate Antigen 125 Increased: 9 people, 37.50%
Stress And Anxiety: 9 people, 37.50%
Insomnia (sleeplessness): 8 people, 33.33%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 8 people, 33.33%

What are the existing conditions these people have? *

Ovarian Cancer (cancer of ovary): 23 people, 95.83%
Neuropathy Peripheral (surface nerve damage): 1 person, 4.17%
Nausea (feeling of having an urge to vomit): 1 person, 4.17%
Malignant Peritoneal Neoplasm (cancer tumour of peritoneum): 1 person, 4.17%
Depression: 1 person, 4.17%

* Approximation only. Some reports may have incomplete information.

Do you take Zejula and have Bruxism?

- Check whether Bruxism is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Zejula:

Zejula (22,014 reports)

Bruxism treatments and more:

Bruxism (7,187 reports)

Browse all side effects of Zejula:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Bruxism:

Bruxism (590 drugs)

Browse all the conditions that are associated with Bruxism:

Bruxism (983 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on niraparib tosylate (the active ingredients of Zejula) and Zejula (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.